MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0075828
Reelabs Private Limited - life sciences in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.69 Cr
▼ 11% YoY
Net profit · FY 2024
₹1.26 Cr
Net margin 7.1%
EBITDA · FY 2024
₹3.48 Cr
EBITDA margin 19.7%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹2.23 Cr
Issued & subscribed
Open charges
₹20.5 Cr
Satisfied ₹35 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
45
Provident fund records
About Reelabs Private Limited
Data last updated:
Reelabs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 23 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2009PTC190531. Its GSTIN is 27AAECR2744P1ZV (Maharashtra).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.23 Cr. It was formerly known as Ree Laboratories Private Limited. It is led by directors including Sunil Haripant Pophale (Managing Director) and Rohit Ramchandra Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor K.K. Chambers Sir.P.T.Road Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.69 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.26 Cr (net margin 7.1%) and EBITDA of ₹3.48 Cr (EBITDA margin 19.7%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 22% over five years.
The company has about 45 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: ReeLabs and Reelabs Wellness. As per MCA filings, the company has open charges of ₹20.5 Cr and satisfied charges of ₹35 Cr on record. Court records list 11 cases involving the company, including 4 filed by the company and 7 filed against it; 7 cases are pending. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022. The company has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 6 micro and small suppliers.
Reelabs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0075828). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reelabs.com.
Company details
CIN U85100MH2009PTC190531
Registration Number 190531
Incorporation Date 23 February 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0075828
Name history
Reelabs has undergone 2 name changes throughout its history. The company was previously known as Ree Labs Private Limited, and Ree Laboratories Private Limited. The current legal name is Reelabs Private Limited.
| Company Name | Status |
|---|---|
| Reelabs Private Limited | Current |
| Ree Labs Private Limited | Previous |
| Ree Laboratories Private Limited | Previous |
Key People
Sunil Haripant Pophale Managing Director Rohit Ramchandra Kulkarni Director Abhijit Shyamsunder Bopardikar Director Recognitions & Rankings of Reelabs
Contact details
Reelabs Private Limited's registered office is in Mumbai, Maharashtra. Its website is reelabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor K.K. Chambers Sir.P.T.Road Fort, Mumbai, Maharashtra, India – 400001
- IndustryLife Sciences, Biotechnology
To see the full contact details of Reelabs Private Limited, buy the company report.
Comprehensive company report
Reelabs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Reelabs operates two associated brands: ReeLabs and Reelabs Wellness. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers stem cell banking from various sources and therapy for medical treatments. | reelabs.com | |
| Offers nutraceuticals, hair, and skin care products for health and wellness improvement. | reelabswellness.com |
Business activity
The main business activity of Reelabs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Reelabs Private Limited, buy the company report.
Financials of Reelabs Private Limited
FY 2025 filings availableReelabs Private Limited reported revenue of ₹17.69 Cr (down 11% YoY) for FY 2024.
Revenue · FY 2024
₹17.69 Cr ▼ 11%
Net profit · FY 2024
₹1.26 Cr margin 7.1%
EBITDA · FY 2024
₹3.48 Cr margin 19.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 25%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 52%
5 years · compounded
▲ 19%
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.7% | ||||
| Net Profit Margin | 7.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reelabs Private Limited, buy the company report.
Board of directors of Reelabs Private Limited
Reelabs has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Ramchandra Kulkarni Also directs: Satiava Healthcare LLP, R K Ubiquitous Strategic Advisors and Consultants LLP, Ibhaan Pharmaceuticals Private Limited and 1 more | Director | 23 Feb 2009 | 17 Years 7 Months | Current |
| Abhijit Shyamsunder Bopardikar Also directs: Satiava Healthcare LLP, Ibhaan Pharmaceuticals Private Limited | Director | 23 Feb 2009 | 17 Years 7 Months | Current |
| Sunil Haripant Pophale | Managing Director | 23 Feb 2009 | 17 Years 7 Months | Current |
Auditor
Reelabs Private Limited is audited by S R RAHALKAR AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R RAHALKAR AND ASSOCIATES | FY 2023 | 108283W |
Shareholding
The shareholding of Reelabs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reelabs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.5 Cr
Satisfied charges
₹35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2024 | 100988188 | Others | ₹20.5 Cr | Open | |
| 17 Nov 2023 | 100823208 | Others | ₹15 Cr | Satisfied | |
| 15 Mar 2022 | 100565701 | Others | ₹5 Cr | Satisfied | |
| 15 Mar 2022 | 100565703 | Others | ₹5 Cr | Satisfied | |
| 29 Dec 2014 | 10544602 | Nkgsb Cooperative Bank Limited | ₹5 Cr | Satisfied |
To see the full charge records of Reelabs Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Reelabs Private Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022.
Total deals
5
Funding rounds
2
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹85 Lakh
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jun 2015 | Rights issue | ₹3.33 Cr | Investors: 3 individuals |
| Mar 2012 | Funding round | ₹30 Lakh | Investors: 3 individuals |
| Mar 2010 | Funding round | ₹55 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Reelabs Private Limited has 11 court cases on record: 4 filed by Reelabs, 7 filed against it. 7 cases are pending and 4 are disposed.
Total cases
11
Filed by the company
4
Filed against the company
7
Pending
7
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 4 | 4 |
| District courts | 2 | 2 | 2 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Cheque dishonour complaint | Filed against the company by Fortis Hospitals Limited | Pending |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Yash Charitable Trust Through Dr. Sushama Nagarkar Authorised Representative Regd. Fiona 3Rd Floor, Juhu, Tara Road ,Mumbai , Maharashtra and 3 others | Pending |
| Bombay High Court | Court case (CARBP) | Filed against the company by an individual | Pending |
| Bombay High Court | Arbitration matter | Filed by the company against an individual | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against an individual | Pending |
To see the full case history of Reelabs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Reelabs Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Indo Amines Limited | |||
| Genetix Biotech Asia Limited | |||
| National Chemical Co | |||
| Salicylates & Chemicals Private Limited |
To see the full MSME payment records of Reelabs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Reelabs Private Limited has a workforce of 45 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
45
Active EPFO establishments
1
Employee growth
-4.26%
GST
Reelabs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECR2744P1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reelabs Private Limited, buy the company report.
Recent activity
Reelabs Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Abhijit Shyamsunder Bopardikar was appointed as Director on 23 Feb 2009.
AGM
Reelabs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Reelabs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 17 Nov 2023 via Charge ID 100823208 with Others was fully satisfied on 14 Nov 2024.
Charges
A charge with Others amounted to Rs. 20.50 Cr with Charge ID 100988188 was registered on 30 Sep 2024.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100823208 was registered on 17 Nov 2023.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100565701 with Others was fully satisfied on 25 Oct 2023.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100565703 with Others was fully satisfied on 25 Oct 2023.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100565701 was registered on 15 Mar 2022.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100565703 was registered on 15 Mar 2022.
Charges
A charge registered on 29 Dec 2014 via Charge ID 10544602 with Nkgsb Cooperative Bank Limited was fully satisfied on 31 Jan 2022.
Charges
A charge registered on 24 Dec 2014 via Charge ID 10544450 with Nkgsb Cooperative Bank Limited was fully satisfied on 31 Jan 2022.
Charges
A charge with Nkgsb Cooperative Bank Limited amounted to Rs. 5.00 Cr with Charge ID 10544602 was registered on 29 Dec 2014.
5 earlier events are in the company report.
Frequently asked questions
Reelabs is an active private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 23 February 2009 (17+ years old) and is registered under CIN U85100MH2009PTC190531.
Reelabs has 3 current directors:
- Sunil Haripant Pophale - Managing Director
- Rohit Ramchandra Kulkarni - Director
- Abhijit Shyamsunder Bopardikar - Director
The latest financial statements of Reelabs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reelabs is 27AAECR2744P1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reelabs is U85100MH2009PTC190531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reelabs has 11 court cases on record: 4 filed by the company and 7 filed against it. 7 are pending. Most are in the high courts.
Reelabs was incorporated on 23 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Reelabs has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹85 Lakh; the latest was in September 2022.
Abhijit Shyamsunder Bopardikar was appointed as Director on 23 Feb 2009. Rohit Ramchandra Kulkarni was appointed as Director on 23 Feb 2009. Sunil Haripant Pophale was appointed as Managing Director on 23 Feb 2009.
Yes, Reelabs is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0075828).
Reelabs has 2 MSME Form 1 returns on record for the period ending Sep 2019, listing 50 overdue payments to 6 micro and small suppliers. The latest return was filed on 20 Mar 2020.